Title:
MEDICINAL PRODUCT
Document Type and Number:
WIPO Patent Application WO/2020/138407
Kind Code:
A1
Abstract:
Provided is a technique for suppressing the change in blending between pemafibrate or a salt of pemafibrate or a solvate of pemafibrate or the salt and a (meth)acrylic acid-based polymer. A medicinal product comprising: an air-tight packaging material; and a pharmaceutical composition which is included in the air-tight packaging material and comprises (A) pemafibrate or a salt of pemafibrate or a solvate of pemafibrate or the salt and (B) a (meth)acrylic acid-based polymer.
Inventors:
NISHIDA CHISA (JP)
Application Number:
PCT/JP2019/051390
Publication Date:
July 02, 2020
Filing Date:
December 27, 2019
Export Citation:
Assignee:
KOWA CO (JP)
International Classes:
A61K31/423; A61K9/14; A61K9/16; A61K9/20; A61K9/48; A61K47/32; A61P1/16; A61P3/06
Domestic Patent References:
| WO2005023777A1 | 2005-03-17 | |||
| WO2019004448A1 | 2019-01-03 | |||
| WO2019004453A1 | 2019-01-03 | |||
| WO2019004452A1 | 2019-01-03 | |||
| WO2019004451A1 | 2019-01-03 | |||
| WO2019004450A1 | 2019-01-03 |
Foreign References:
| US7109226B2 | 2006-09-19 |
Other References:
ANONYMOUS: "Report on the deliberation results of parmodia tablets 0.1 mg [Common name: pemafibrate]", PMDA REPORT ON THE DELIBERATION RESULTS, 3 July 2017 (2017-07-03), pages 1 - 74, XP009518270
FRUCHART JC., CARDIOVASC DIABETOL, vol. 12, 2013, pages 82
"Handbook of Pharmaceutical Excipients", PHARMACEUTICAL PRESS
FRUCHART JC., CARDIOVASC DIABETOL, vol. 12, 2013, pages 82
"Handbook of Pharmaceutical Excipients", PHARMACEUTICAL PRESS
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF:
Previous Patent: PHARMACEUTICAL COMPOSITION
Next Patent: METHOD FOR PRODUCING CURABLE SILICONE SHEET HAVING HOT MELT PROPERTIES
Next Patent: METHOD FOR PRODUCING CURABLE SILICONE SHEET HAVING HOT MELT PROPERTIES